Gapping down
In reaction to disappointing earnings/guidance:
- FTDR -24%, GSKY -16.8%, RYAM -13.5%, COHU -12.7%, INSY -10.3% (also announces that it has commenced a process to review strategic alternatives for its portfolio of opioid-related assets), CDEV -9.8%, TWOU -8.8%, UNVR -7.7%, NBIX -7.5%, ORA -6.4%, IIN -6.3%, NVRO -6.3%, PTCT -5.8%, MAR -5.5%, OAS -5.2%, CAR -5%, SBRA -4.7%, BE -4.4%, THC -4.4%, BDX -4.3%, LPI -3.7%, BBX -3.2%, ONCE -2.9%, ANDE -2.7%, NBRV -2.6%, DVAX -1.3%, CPLG -1.3%, IFF -1.2%, EMR -1.2%, VVV -1.1%, FAST -1.1% (Oct sales) BCRX -1%, IONS -1%
Other news:
- NEOS -14.2% (announces proposed underwritten public offering of common stock)
- HTZ -1.3% (following CAR results)
Analyst comments:
- NYT -3.6% (downgraded to Underweight at Barclays)
- SPLK -2.7% (downgraded to to Mkt Perform at Bernstein)
![]()